Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
United Kingdom
In shortMD Medical Group Investments PLC is profitable, generates cash and holds more cash than debt, with revenue stable (+0.0% last year).
Financial health
Strong
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 19.7% | 82/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 18.1% | 92/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 18.4% | 92/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 18.1% | 100/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.46× | 55/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.02× | 100/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 10.06× | 82/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 8.11 | 100/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 26.3% | 100/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.45× | 100/100 |
| Years with positive free cash flow (last 5) | 3 of 3 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 3 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 2 | 100/100 |
| Revenue growth volatility | 22.5% | 28/100 |
| Operating margin volatility | 3.3% | 79/100 |
Weight in the score: 20%
Fiscal year 2022 · change vs prior year
European data comes from annual reports in ESEF format (since 2020). Industry and ticker are not provided by this source.
Annual figures as reported. Hover a bar or point for the exact value.
The last 3 fiscal years from the company's annual reports.
RUB millions; negative values in parentheses.
| Fiscal year | FY20 | FY21 | FY22 |
|---|---|---|---|
| Revenue | 19,133 | 25,220 | 25,222 |
| Cost of revenue | 12,007 | 15,232 | 15,429 |
| Gross profit | 7,127 | 9,988 | 9,793 |
| Selling, general & admin | 2,807 | 3,402 | 3,513 |
| Operating income | 4,504 | 6,622 | 4,969 |
| Interest expense | 537 | 549 | 494 |
| Pre-tax income | 4,338 | 6,158 | 4,726 |
| Income tax | 4.8 | 15 | 7.6 |
| Net income | 4,196 | 6,003 | 4,560 |
| Diluted EPS | RUB55.86 | RUB79.91 | – |
8.11 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: filings.xbrl.org (ESEF). Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2022 · Data updated Dec 31, 2022